Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma By Ogkologos - February 10, 2025 739 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ESOPEC study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR FDA Approves Pembrolizumab with Enfortumab Vedotin-ejfv for Muscle Invasive Bladder Cancer December 15, 2025 Inhibition of GDF-15 with Ponsegromab Results in Increased Weight Gain and... September 20, 2024 What to Know When Searching for Cancer Information Online: An Expert... December 7, 2021 ASCO Annual Meeting 2023: Improving Outcomes in Glioma, Hodgkin Lymphoma, Lung... June 4, 2023 Load more HOT NEWS EMA Recommends Granting a Marketing Authorisation for Pomalidomide Viatris EMA Recommends Granting a Marketing Authorisation for Plerixafor Accord Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer Free Rides to Screening Appointments Thanks to Woman Who Lost Mother...
